[HTML][HTML] Vilazodone for major depression in adults: pharmacological profile and an updated review for clinical practice
M Chauhan, R Parry, WV Bobo - Neuropsychiatric Disease and …, 2022 - ncbi.nlm.nih.gov
This article provides an updated review of the pharmacological profile and available efficacy
and tolerability/safety data for vilazodone, one of the most recent antidepressant drugs to be …
and tolerability/safety data for vilazodone, one of the most recent antidepressant drugs to be …
Antidepressants
Major depressive disorder (MDD) is a common, typically recurrent, sometimes chronic, and
very disabling disorder, with a lifetime prevalence of 20%. Moreover, antidepressant …
very disabling disorder, with a lifetime prevalence of 20%. Moreover, antidepressant …